Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur P Staddon

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
JBJS Case Connector|December 19, 2017
"Residual Osteocytic Lesion": Effect of Denosumab (AMG 162) Treatment on the Morphology and Immunophenotype of Giant-Cell Tumor: A Report of Two CasesNicole D Riddle, Krister Jones, Arthur P Staddon, et al.
Cancer Medicine|January 12, 2019
Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and developmentDaniel Y Lee, Arthur P Staddon, Jacob E Shabason, et al.
The Oncologist|April 19, 2002
Osteogenic sarcoma presenting with lung metastasisArthur P Staddon, Richard Lackman, Keith Robinson, et al.
American Journal of Clinical Oncology|September 15, 2010
Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapyVincent M Moretti, Eileen A Crawford, Arthur P Staddon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 25, 2007
Phospho-S6 ribosomal protein: a potential new predictive sarcoma marker for targeted mTOR therapyO Hans Iwenofu, Richard D Lackman, Arthur P Staddon, et al.
American Journal of Clinical Oncology|September 23, 2009
Treatment of adult rhabdomyosarcomaChristian M Ogilvie, Eileen A Crawford, Rachel L Slotcavage, et al.
International Journal of Surgical Pathology|October 2, 2018
Combined Sclerosing and Spindle Cell Rhabdomyosarcoma in Previous Craniotomy Site: A Case Report and a Review of the LiteratureHongxing Gui, Elliott Lhospital, Arthur P Staddon, et al.
Cancer|August 24, 2017
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcomaBrian L Samuels, Sant P Chawla, Neeta Somaiah, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapyChao Hui Huang, Michael M Millenson, Eric J Sherman, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2014
Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomasJean-Yves Blay, Michael G Leahy, Binh Bui Nguyen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
JBJS Case Connector|December 19, 2017
"Residual Osteocytic Lesion": Effect of Denosumab (AMG 162) Treatment on the Morphology and Immunophenotype of Giant-Cell Tumor: A Report of Two CasesNicole D Riddle, Krister Jones, Arthur P Staddon, et al.
Cancer Medicine|January 12, 2019
Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and developmentDaniel Y Lee, Arthur P Staddon, Jacob E Shabason, et al.
The Oncologist|April 19, 2002
Osteogenic sarcoma presenting with lung metastasisArthur P Staddon, Richard Lackman, Keith Robinson, et al.
American Journal of Clinical Oncology|September 15, 2010
Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapyVincent M Moretti, Eileen A Crawford, Arthur P Staddon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 25, 2007
Phospho-S6 ribosomal protein: a potential new predictive sarcoma marker for targeted mTOR therapyO Hans Iwenofu, Richard D Lackman, Arthur P Staddon, et al.
American Journal of Clinical Oncology|September 23, 2009
Treatment of adult rhabdomyosarcomaChristian M Ogilvie, Eileen A Crawford, Rachel L Slotcavage, et al.
International Journal of Surgical Pathology|October 2, 2018
Combined Sclerosing and Spindle Cell Rhabdomyosarcoma in Previous Craniotomy Site: A Case Report and a Review of the LiteratureHongxing Gui, Elliott Lhospital, Arthur P Staddon, et al.
Cancer|August 24, 2017
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcomaBrian L Samuels, Sant P Chawla, Neeta Somaiah, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapyChao Hui Huang, Michael M Millenson, Eric J Sherman, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2014
Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomasJean-Yves Blay, Michael G Leahy, Binh Bui Nguyen, et al.
Pageof 2